glp 1 agonist diarrhea glp-1 side effects Eating Well on Your GLP-1 Journey: A Guide for Maximizing GLP-1 Medications Infographic | Medidex

[DOI] [PubMed] [Google Scholar] 14.After the LEADER trial and SUSTAIN-6, how do we explain the cardiovascular benefits of some GLP-1 receptor agonists

The array sensitivity analysis indicated that the two exposure groups would need to have at least a 15 percentage point imbalance in an unmeasured confounder with a confounder-outcome risk ratio of 3.5 or a 30 percentage point imbalance with a confounder-outcome risk ratio of 2.0 to bias our results by at least 25% (supplementary figure S3A)

Both drugs commonly cause nausea, vomiting, and diarrhea

2 T2D can cause serious complications, including neuropathy, retinopathy, nephropathy (kidney damage), and cardiovascular disease